REVIEW 4 major objections 2 minor 5 references
Risk-Aware Robust Learning: Reducing Clinical Risk under Label Noise in Medical Image Classification
T0 review · 4 major / 2 minor · reviewed 2026-05-08 · grok-4.3
Pith's one-line read Noise-robust methods for medical image classification do not ensure clinical safety under label noise, but integrating cost-sensitive optimization reduces risk while preserving utility.
desk verdict The paper shows that standard noise-robust methods leave high false-negative risk on noisy medical images while a cost-sensitive addition lowers it, but the symmetric simulated noise on binarized small datasets weakens how much the result generalizes. read the letter →
The pith
A machine-rendered reading of the paper's core claim, the machinery that carries it, and where it could break.
The reading
What carries the argument
A Global Risk cost formulation that assigns higher penalties to false negatives, integrated into noise-robust training pipelines to optimize for clinical safety in binary medical image classification.
What would settle it
Collecting real multi-annotator labels on medical images with known patient outcomes and comparing the clinical risk of standard robust models versus cost-sensitive variants on that data.
Extended reading notes
Core claim
The paper establishes that the robustness of methods such as Coteaching, DivideMix, UNICON, and GMM-based filtering to label noise does not guarantee low clinical risk when evaluated with a Global Risk formulation that explicitly penalizes false negatives. On binarized versions of DermaMNIST and PathMNIST under 20% and 40% label noise, these methods maintain balanced accuracy but can exhibit elevated risk. Integrating cost-sensitive optimization into the noise-robust training process significantly reduces the clinical risk metric while maintaining model utility.
Load-bearing premise
That the simulated label noise rates and the specific Global Risk cost formulation based on binarized datasets sufficiently represent real clinical annotation errors and the asymmetric consequences for patients.
Editorial extensions
If this is right
- Robustness to label noise alone is insufficient to ensure low clinical risk in medical diagnosis tasks.
- Cost-sensitive optimization can be combined with existing noise-robust methods to achieve both noise tolerance and risk reduction.
- Clinical risk must be explicitly modeled with asymmetric costs to evaluate and improve medical classifiers under noisy labels.
- The approach applies to datasets like skin lesion and histopathology images at moderate to high noise levels.
Reading between the lines
- Extending this to multi-class settings with varying risk profiles per class could further improve real-world applicability.
- Using actual inter-observer variability data from clinics instead of simulated noise would provide stronger validation.
- This risk-aware approach might generalize to other noisy label problems in high-stakes domains like radiology or autonomous systems.
Signed reviews
Editorial analysis
A structured set of objections, weighed in public.
Referee Report
Summary. The paper claims that state-of-the-art noise-robust methods (Co-teaching, DivideMix, UNICON, GMM filtering) do not guarantee clinical safety under label noise in medical image classification, as their accuracy robustness fails to control a cost-sensitive Global Risk metric that penalizes false negatives more heavily; it further claims that integrating cost-sensitive optimization into these methods significantly reduces Global Risk while preserving model utility, based on systematic experiments with symmetric noise injection on binarized DermaMNIST and PathMNIST at 0/20/40% noise rates.
Significance. If the results hold, the work highlights a gap between accuracy-based robustness and clinical safety in noisy-label medical imaging, providing evidence that cost-sensitive integration can mitigate asymmetric error costs without sacrificing utility; this could influence evaluation practices in safety-critical ML applications.
major comments (4)
- [§4 (Experimental Setup)] The central claim that 'robustness does not guarantee clinical safety' rests on symmetric uniform label flips at fixed rates; this noise model does not capture real clinical annotation errors, which are typically asymmetric (higher FN on ambiguous cases), feature-correlated, and arising from inter-observer variability, as noted in the abstract's own motivation.
- [§4.1 (Datasets)] Binarization of DermaMNIST (originally 7 classes) and PathMNIST (originally 9 classes) into binary tasks is used without justification or ablation; this alters the clinical diagnostic scenario and may not preserve the asymmetric consequences the Global Risk metric is intended to model.
- [§3.2 (Risk Metric)] The Global Risk formulation includes a free parameter (false_negative_cost_weight) whose value is not subjected to sensitivity analysis; different choices could change which methods appear safer and whether the reported risk reductions remain significant.
- [§3.3 (Proposed Integration)] No details are provided on how cost-sensitive optimization is integrated into each baseline (e.g., loss modifications in DivideMix or UNICON), making it impossible to determine whether the observed Global Risk improvements are due to the proposed integration or to other implementation choices.
minor comments (2)
- [Abstract] Abstract contains typo 'mantaining' (should be 'maintaining') and inconsistent method naming ('Coteaching' vs. standard 'Co-teaching').
- [§4] The manuscript should report the number of random seeds, exact train/val/test splits, and any statistical significance tests for the risk comparisons to support the 'systematic' evaluation claim.
Simulated Author's Rebuttal
We thank the referee for the constructive comments, which help clarify the scope and presentation of our work. We respond to each major comment below and indicate planned revisions to address valid concerns while preserving the core contributions.
read point-by-point responses
-
Referee: [§4 (Experimental Setup)] The central claim that 'robustness does not guarantee clinical safety' rests on symmetric uniform label flips at fixed rates; this noise model does not capture real clinical annotation errors, which are typically asymmetric (higher FN on ambiguous cases), feature-correlated, and arising from inter-observer variability, as noted in the abstract's own motivation.
Authors: We acknowledge that symmetric uniform noise is a controlled simplification and does not fully replicate the asymmetric, feature-dependent, and inter-observer nature of real clinical label errors. This model was selected, following common practice in the noise-robust learning literature, to isolate the impact of noise rate on the gap between accuracy robustness and clinical risk. The observed failure of standard methods to control Global Risk even under this setting still supports the central claim. In revision we will add an expanded limitations paragraph discussing the noise model and outlining future directions for more realistic clinical noise simulation. revision: partial
-
Referee: [§4.1 (Datasets)] Binarization of DermaMNIST (originally 7 classes) and PathMNIST (originally 9 classes) into binary tasks is used without justification or ablation; this alters the clinical diagnostic scenario and may not preserve the asymmetric consequences the Global Risk metric is intended to model.
Authors: Binarization creates well-defined positive/negative classes for which the asymmetric false-negative costs in the Global Risk metric are clinically interpretable. We will insert explicit justification in Section 4.1 explaining this alignment with binary diagnostic tasks and, space permitting, include a short ablation on alternative class groupings to demonstrate robustness of the reported trends. revision: yes
-
Referee: [§3.2 (Risk Metric)] The Global Risk formulation includes a free parameter (false_negative_cost_weight) whose value is not subjected to sensitivity analysis; different choices could change which methods appear safer and whether the reported risk reductions remain significant.
Authors: The default weight of 5 was chosen to reflect typical clinical priorities, yet we agree that sensitivity analysis strengthens the claims. We will add experiments in the revision varying the weight over {2, 5, 10} and show that the risk-reduction benefits of cost-sensitive integration remain consistent across this range. revision: yes
-
Referee: [§3.3 (Proposed Integration)] No details are provided on how cost-sensitive optimization is integrated into each baseline (e.g., loss modifications in DivideMix or UNICON), making it impossible to determine whether the observed Global Risk improvements are due to the proposed integration or to other implementation choices.
Authors: Section 3.3 describes the high-level replacement of the standard loss with a cost-sensitive weighted loss. To improve clarity and reproducibility we will append concrete implementation details together with pseudocode showing the exact loss modifications for Co-teaching, DivideMix, UNICON, and the GMM filter. revision: yes
Circularity Check
No circularity in empirical evaluation
full rationale
The paper is an empirical study that evaluates existing noise-robust methods (Co-teaching, DivideMix, UNICON, GMM) on binarized DermaMNIST and PathMNIST under simulated symmetric label noise at fixed rates, measuring both balanced accuracy and a separately defined cost-sensitive Global Risk that weights false negatives higher. No derivation chain, first-principles predictions, fitted parameters renamed as outputs, or self-citation load-bearing steps are present; all claims rest on direct experimental comparisons with externally specified noise models and risk formulations. The setup is self-contained against the chosen benchmarks and does not reduce any result to its own inputs by construction.
Assumptions & free parameters
free parameters (1)
- false_negative_cost_weight
assumptions (1)
- domain assumption Binarized DermaMNIST and PathMNIST with injected symmetric noise are representative of real clinical label noise.
Cite this review
Pith. "Pith review of Risk-Aware Robust Learning: Reducing Clinical Risk under Label Noise in Medical Image Classification." pith.science (2026). https://pith.science/paper/2604.23875
@misc{pith2026260423875,
author = {Pith},
title = {Pith review of: Risk-Aware Robust Learning: Reducing Clinical Risk under Label Noise in Medical Image Classification},
year = {2026},
howpublished = {\url{https://pith.science/paper/2604.23875}},
note = {Machine review of arXiv:2604.23875}
}
read the original abstract
Noisy labels are a pervasive challenge in medical image classification, where annotation errors arise from inter-observer variability and diagnostic ambiguity. Although several noise-robust learning methods have been proposed, their evaluation predominantly relies on accuracy-oriented metrics, overlooking the clinical implications of asymmetric error costs. In medical diagnosis, a false negative (missed disease) carries substantially higher consequences than a false positive (false alarm), as delayed treatment can directly impact patient outcomes. In this work, we investigate whether noise-robust training methods preserve clinical safety under label noise. We conduct a systematic risk-aware evaluation of the state-of-the-art noise-robust methods Coteaching, DivideMix, UNICON, and a GMM-based filtering approach on binarized DermaMNIST and PathMNIST datasets under clean and label noise rates of 20%, and 40%. Beyond balanced accuracy, we adopt a cost-sensitive Global Risk formulation that explicitly penalizes false negatives. Our analysis reveals that the robustness of state-of-the-art methods does not guarantee clinical safety. Furthermore, we demonstrate that integrating cost-sensitive optimization into noise-robust training significantly reduces clinical risk, while mantaining model utility. These findings demonstrate that noise-robust learning must be evaluated through a clinical risk lens, and that combining robust training with cost-sensitive optimization can meaningfully reduce risk in noisy-label medical imaging scenarios.
Figures
Reference graph
Works this paper leans on
-
[1]
Araf, I., Idri, A., and Chairi, I. (2024). Cost-sensitive learning for imbalanced medical data: a review.Artificial Intelligence Review, 57(4):80. Arpit, D., Jastrzebski, S., Ballas, N., Krueger, D., Bengio, E., Kanwal, M. S., Maharaj, T., Fischer, A., Courville, A., Bengio, Y ., and Lacoste-Julien, S. (2017). A closer look at memorization in deep network...
work page 2024
-
[2]
(2024).Machine Learning with Noisy Labels: Definitions, Theory, Tech- niques and Solutions
Carneiro, G. (2024).Machine Learning with Noisy Labels: Definitions, Theory, Tech- niques and Solutions. Elsevier. Chan, H.-P., Samala, R. K., Hadjiiski, L. M., and Zhou, C. (2020). Deep learning in medical image analysis.Deep learning in medical image analysis: challenges and applications, pages 3–21. Collell, G., Prelec, D., and Patil, K. R. (2018). A s...
work page 2024
-
[3]
Haimerl, M. and Reich, C. (2025). Risk-based evaluation of machine learning-based clas- sification methods used for medical devices.BMC Medical Informatics and Decision Making, 25(1):126. Han, B., Yao, Q., Yu, X., Niu, G., Xu, M., Hu, W., Tsang, I., and Sugiyama, M. (2018). Co-teaching: Robust training of deep neural networks with extremely noisy labels. ...
work page 2025
-
[4]
He, K., Zhang, X., Ren, S., and Sun, J. (2016). Deep residual learning for image recogni- tion. InIEEE/CVF Conference on Computer Vision and Pattern Recognition (CVPR), pages 770–778. Jiang, L., Zhou, Z., Leung, T., Li, L.-J., and Fei-Fei, L. (2018). Mentornet: Learning data- driven curriculum for very deep neural networks on corrupted labels. InInternati...
work page 2016
-
[5]
Yang, J., Shi, R., Wei, D., Liu, Z., Zhao, L., Ke, B., Pfister, H., and Ni, B. (2023). Medmnist v2 – a large-scale lightweight benchmark for 2d and 3d biomedical image classification.Scientific Data, 10(1):41. Zhang, C., Bengio, S., Hardt, M., Recht, B., and Vinyals, O. (2021). Understanding deep learning (still) requires rethinking generalization.Communi...
work page 2023
Reviewed May 8, 2026 · model on record in the stance chip above.
Discussion (0). Continue with ORCID to comment.